Patent · US Active

GNAQ targeted dsRNA compositions and methods for inhibiting expression

US8324368B2 · kind B2 · utility

8Cited by
3References
36Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 10, 2009
Grant dateDec 4, 2012
Priority date
Expiry dateJul 23, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2320/51
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to a double-stranded ribonucleic acid (dsRNA) targeting a G-alpha q subunit (GNAQ) of a heterotrimeric G gene, and methods of using the dsRNA to inhibit expression of GNAQ.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.